Regulatory Impact of Manufacturing Site Transfers

📢 DDReg Knowledge Capsule – Episode [28]This podcast covers the analysis of the regulatory complexities involved when relocating production facilities for pharmaceuticals, biologics, and medical devices. Moving a manufacturing site is not a simple logistical task but a significant material change that requires specific approvals and notifications across different global jurisdictions. The text highlights critical compliance pillars, such as rigorous process validation, the integration of quality management systems, and the strategic timing of submissions to avoid supply chain gaps. It also outlines the severe financial and legal risks associated with inadequate transition management, including product recalls and regulatory sanctions.https://resource.ddregpharma.com/blogs/regulatory-impact-manufacturing-site-transfers/